MobiHealth News November 14, 2025
Anthony Vecchione

The company will use the funds to add on more specialties and invest in an AI-enabled pharmacy management system.

House Rx, a healthcare technology platform that focuses on specialty pharmacy, announced it raised $55 million in Series B equity and debt, bringing the company’s total capital to $100 million.

The round was led by New Enterprise Associates and Town Hall Ventures.

LRVHealth, First Round Capital, Bessemer Venture Partners and Silicon Valley Bank, participated in the round.

WHAT IT DOES

In contrast to the traditional pharmacy benefit manager-owned business model, House Rx includes a nationwide network of locally owned brick-and-mortar specialty dispensaries inside specialty clinics.

The House Rx platform aims to support all aspects of medically integrated dispensing...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Investments, Pharma, Pharma / Biotech, Trends
Navigating the Shift: 2026 Medicare Drug Pricing and the Future of Pharmacy
Podcast: Medicaid vs. 340B: A Drug Pricing Clash (Sayeh Nikpay)
Q&A: New PQA Resource Highlights 40 Projects Targeting Social Determinants of Health
NVIDIA and Lilly Announce Co-Innovation AI Lab to Accelerate Drug Discovery
The Future of Pharmacovigilance Technology: How AI and Automation Are Redefining Drug Safety

Share Article